Companies: 10,795·Total market cap: $144.5T
Nautilus Biotechnology, Inc.

Nautilus Biotechnology, Inc.

NAUTNASDAQHealthcare● Active
$2.33
$-0.06(-2.51%)
Market Cap$296093732
P/E Ratio
52W High$4.31
52W Low$0.62

Nautilus Biotechnology, Inc.(NAUT)内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签;可在本季度与近12个月之间切换;下方为季度图与交易明细。

SEC EDGAR · FMP · NAUT · 截至 2026年6月8日

活动摘要

买入笔数

5

P-Purchase only

卖出笔数

2

近12个月

买卖比

2.50

Buy/Sell (by trades)

整体情绪

偏多
↑ Buy 71%仅显示有效交易 · 排除RSU归属29% Sell ↓

Nautilus Biotechnology, Inc.内部人在过去近12个月净买入股份,可能反映对公司前景的信心。

数据来源:SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月8日

NAUT 季度内部人买卖趋势

NAUT 内幕交易卖出 · NAUT 内幕交易买入 · 季度活动

买入总量(含股权归属)卖出总量
5.0M2.5M0
2025 Q3
2025 Q4
2026 Q1
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

数据来源:SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 8, 2026

活跃内部人

近12个月交易最活跃 · NAUT CEO内幕交易

显示全部内部人 · 点击卡片过滤下方交易表

按reportingName聚合 · 近12月交易次数Top5 · 无额外API

近期内幕交易记录

NAUT 高管卖出股份 · NAUT 董事内幕交易 · SEC Form 4申报

显示最近 30 条 · 普通股 · 仅Form 4

横向滑动查看全部列

AH Equity Partners Bio II, L.L.C.

10 percent owner

Sale

日期

Jun 2

股数

4,615,974

均价

$2.35

总金额

$10.85M ⚡

View Form 4 on SEC.gov

AH Equity Partners Bio II, L.L.C.

10 percent owner

Sale

日期

Jun 2

股数

384,026

均价

$2.35

总金额

$902K

View Form 4 on SEC.gov

Patel Sujal M

CEO, President, and Secretary · Director

Purchase

日期

Mar 4

股数

25,000

均价

$2.61

总金额

$65K

View Form 4 on SEC.gov

Suzuki Kentaro

Chief Marketing Officer

Purchase

日期

Nov 6

股数

4,000

均价

$1.49

总金额

$6K

View Form 4 on SEC.gov

Patel Sujal M

CEO, President, and Secretary · Director

Purchase

日期

Sep 8

股数

83,500

均价

$0.68

总金额

$57K

View Form 4 on SEC.gov

Patel Sujal M

CEO, President, and Secretary · Director

Purchase

日期

Sep 5

股数

116,500

均价

$0.67

总金额

$79K

View Form 4 on SEC.gov

Murphy Matthew B.

General Counsel

Purchase

日期

Sep 4

股数

20,000

均价

$0.64

总金额

$13K

View Form 4 on SEC.gov

Mowry Anna

CFO and Treasurer

Purchase

日期

May 29

股数

15,000

均价

$0.77

总金额

$11K

View Form 4 on SEC.gov

Mallick Parag

Chief Scientist · Director

Purchase

日期

May 12

股数

1,500

均价

$0.73

总金额

$1K

View Form 4 on SEC.gov

Mallick Parag

Chief Scientist · Director

Purchase

日期

May 8

股数

12,000

均价

$0.73

总金额

$9K

View Form 4 on SEC.gov

Patel Sujal M

CEO, President, and Secretary · Director

Purchase

日期

Mar 20

股数

23,933

均价

$1.00

总金额

$24K

View Form 4 on SEC.gov

Patel Sujal M

CEO, President, and Secretary · Director

Purchase

日期

Mar 19

股数

53,300

均价

$0.99

总金额

$53K

View Form 4 on SEC.gov

Godwin Mary E.

Senior VP, Operations

Option

日期

Sep 23

股数

47,031

均价

$0.46

总金额

$22K

View Form 4 on SEC.gov

Godwin Mary E.

Senior VP, Operations

Sale

日期

Sep 23

股数

47,031

均价

$2.87

总金额

$135K

View Form 4 on SEC.gov

Godwin Mary E.

Senior VP, Operations

Option

日期

Sep 17

股数

35,000

均价

$0.46

总金额

$16K

View Form 4 on SEC.gov

Godwin Mary E.

Senior VP, Operations

Sale

日期

Sep 17

股数

35,000

均价

$2.85

总金额

$100K

View Form 4 on SEC.gov

Patel Sujal M

CEO, President, and Secretary · Director

Purchase

日期

Mar 11

股数

12,044

均价

$2.84

总金额

$34K

View Form 4 on SEC.gov

Patel Sujal M

CEO, President, and Secretary · Director

Purchase

日期

Mar 8

股数

2,430

均价

$2.99

总金额

$7K

View Form 4 on SEC.gov

Patel Sujal M

CEO, President, and Secretary · Director

Purchase

日期

Mar 7

股数

18,854

均价

$2.89

总金额

$54K

View Form 4 on SEC.gov

Patel Sujal M

CEO, President, and Secretary · Director

Purchase

日期

Mar 6

股数

9,267

均价

$2.70

总金额

$25K

View Form 4 on SEC.gov

Patel Sujal M

CEO, President, and Secretary · Director

Purchase

日期

Mar 5

股数

7,405

均价

$2.65

总金额

$20K

View Form 4 on SEC.gov

Sankar Subramanian

Senior VP, Product Development

Purchase

日期

Sep 27

股数

5,000

均价

$2.03

总金额

$10K

View Form 4 on SEC.gov

Sankar Subramanian

Senior VP, Product Development

Purchase

日期

Sep 26

股数

10,000

均价

$2.02

总金额

$20K

View Form 4 on SEC.gov

Weld Gwen E

CPO

Purchase

日期

Sep 23

股数

30,000

均价

$2.03

总金额

$61K

View Form 4 on SEC.gov

Sankar Subramanian

Senior VP, Product Development

Purchase

日期

Sep 16

股数

35,000

均价

$2.16

总金额

$75K

View Form 4 on SEC.gov

⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股

1 / 2

数据来源:SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 NAUT 内幕交易

NAUT 内幕交易

Nautilus Biotechnology, Inc.(NAUT)内幕交易数据来源于公司内部人(包括Patel Sujal M (CEO, President, and Secretary · Director), AH Equity Partners Bio II, L.L.C. (10 percent owner), Suzuki Kentaro (Chief Marketing Officer))提交的SEC Form 4申报文件。过去12个月内,4位内部人向SEC提交了交易申报。NAUT内部人近期主要在买入,这可能反映预设的10b5-1计划执行,而非方向性判断。

如需查看Nautilus Biotechnology, Inc.机构持仓比例和内部人持股百分比,请访问持仓(Ownership)标签页 → Ownership tab →

买卖信号逻辑
acquisitionOrDisposition字段:
A = 买入 · D = 卖出(处置)
RSU归属(M-Exempt)不计入情绪判断
Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件
10b5-1预设交易计划,允许内部人按计划自动卖出
Open Mkt公开市场直接买卖(不含股权奖励和期权行权)

常见问题

NAUT 内幕交易 · 5个问题

Nautilus Biotechnology, Inc.(NAUT)的内部人包括高管和董事,如Patel Sujal M (CEO, President, and Secretary · Director), AH Equity Partners Bio II, L.L.C. (10 percent owner), Suzuki Kentaro (Chief Marketing Officer)等。过去12个月内,4位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

NAUT 董事内幕交易NAUT 内部人名单Nautilus Biotechnology, Inc. 高管内幕活动

数据来源:FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026